Clinical characteristics of concurrent primary aldosteronism and renal artery stenosis: A retrospective case–control study

References

• Siddiqui MA, Mittal PK, Little BP, Miller FH, Akduman EI, Ali K, Sartaj S, Moreno CC. Secondary Hypertension and Complications: Diagnosis and Role of Imaging. Radiographics 2019; 39(4): 1036-1055. doi:10.1148/rg.2019180184.
   Google Scholar
• Charles L, Triscott J, Dobbs B. Secondary hypertension: discovering the underlying cause. Am Fam Physician. 2017;96(7):453–61.
   PubMed Web of Science ®Google Scholar
• Ippersiel V, Rosiere A, Michel L, Donckier J. Misleading diagnosis of renal artery stenosis by magnetic resonance angiography in a patient with primary aldosteronism. Acta Chir Belg. 2012;112(4):302–06. doi:10.1080/00015458.2012.11680843.
   PubMed Web of Science ®Google Scholar
• Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003;16(11 Pt 1):925–30. doi:10.1016/S0895-7061(03)01032-X.
   PubMed Web of Science ®Google Scholar
• Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr., Montori VM, Endocrine S. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266–81. doi:10.1210/jc.2008-0104.
   PubMed Web of Science ®Google Scholar
• Moraitis A, Stratakis C. Adrenocortical causes of hypertension. Int J Hypertens. 2011;2011:624691. doi:10.4061/2011/624691.
   PubMedGoogle Scholar
• Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916. doi:10.1210/jc.2015-4061.
   PubMed Web of Science ®Google Scholar
• Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor SC, Gifford RW. Vidt DG: the changing clinical spectrum of primary aldosteronism. Am J Med. 1983;74(4):641–51. doi:10.1016/0002-9343(83)91022-7.
   PubMed Web of Science ®Google Scholar
• Dworkin LD. Cooper CJ: clinical practice. Renal-artery stenosis. N Engl J Med. 2009;361(20):1972–78. doi:10.1056/NEJMcp0809200.
   PubMed Web of Science ®Google Scholar
• Karagiannis A, Tziomalos K, Dona K, Pyrpasopoulou A, Kartali N, Athyros V, Zamboulis C. Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient. QJM. 2005;98(12):913–15. doi:10.1093/qjmed/hci143.
   PubMed Web of Science ®Google Scholar
• Pizzolo F, Pavan C, Guarini P, Trabetti E, Girelli D, Corrocher R, Olivieri O. Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease. J Hypertens. 2005;23(11):2041–47. doi:10.1097/01.hjh.0000187260.32567.75.
   PubMed Web of Science ®Google Scholar
• Oueslati I, Khiari K, Khessairi N, McHirgui N, Ben Abdallah N. Resistant hypertension secondary to coexisting primary hyperaldosteronism and renal artery stenosis. Tunis Med. 2018;96(5):326–28.
   PubMedGoogle Scholar
• Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2014;35(19):1245–54. doi:10.1093/eurheartj/eht534.
   PubMed Web of Science ®Google Scholar
• Vongpatanasin W. Resistant hypertension: a review of diagnosis and management. JAMA. 2014;311(21):2216–24. doi:10.1001/jama.2014.5180.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12. doi:10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Arlt W. A detour guide to the endocrine society clinical practice guideline on case detection, diagnosis and treatment of patients with primary aldosteronism. Eur J Endocrinol. 2010;162(3):435–38. doi:10.1530/EJE-09-0869.
   PubMed Web of Science ®Google Scholar
• Morera J, Reznik Y. Management of endocrine disease: the role of confirmatory tests in the diagnosis of primary aldosteronism. Eur J Endocrinol 2019; 180(2): R45-R58.doi:10.1530/EJE-18-0704.
   Google Scholar
• Gyamlani G, Headley CM, Naseer A, Valaulikar GS, Geraci SA. Primary aldosteronism: diagnosis and management. Am J Med Sci. 2016;352(4):391–98. doi:10.1016/j.amjms.2016.06.015.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Bertello C, Rossato D, Mengozzi G, Milan A, Garrone C, Giraudo G, Passarino G, Garabello D, Verhovez A, et al. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008;93(4):1366–71. doi:10.1210/jc.2007-2055.
   PubMed Web of Science ®Google Scholar
• Brown CA, Bouldin MJ, Blackston JW, Duddleston DN, Shepherd JM, Hicks GS. Hyperaldosteronism: the internist’s hypertensive disease. Am J Med Sci. 2002;324(4):227–31. doi:10.1097/00000441-200210000-00010.
   PubMed Web of Science ®Google Scholar
• Herrmann SM, Textor SC. Current concepts in the treatment of renovascular hypertension. Am J Hypertens. 2018;31(2):139–49. doi:10.1093/ajh/hpx154.
   PubMed Web of Science ®Google Scholar
• Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293–300. doi:10.1016/j.jacc.2006.07.059.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89(3):1045–50. doi:10.1210/jc.2003-031337.
   PubMed Web of Science ®Google Scholar
• Stowasser M, Ahmed AH, Pimenta E, Taylor PJ, Gordon RD. Factors affecting the aldosterone/renin ratio. Horm Metab Res. 2012;44(3):170–76. doi:10.1055/s-0031-1295460.
   PubMed Web of Science ®Google Scholar
• Smith A, Gaba RC, Bui JT, Minocha J. Management of renovascular hypertension. Tech Vasc Interv Radiol. 2016;19(3):211–17. doi:10.1053/j.tvir.2016.06.006.
   PubMed Web of Science ®Google Scholar
• Chrissobolis S. Vascular consequences of aldosterone excess and mineralocorticoid receptor antagonism. Curr Hypertens Rev. 2017;13(1):46–56. doi:10.2174/1573402113666170228151402.
   PubMed Web of Science ®Google Scholar
• Cachofeiro V, Miana M, de Las Heras N, Martin-Fernandez B, Ballesteros S, Fernandez-Tresguerres J, Lahera V. Aldosterone and the vascular system. J Steroid Biochem Mol Biol. 2008;109(3–5):331–35. doi:10.1016/j.jsbmb.2008.03.005.
   PubMed Web of Science ®Google Scholar
• Brewster UC, Setaro JF, Perazella MA. The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci. 2003;326(1):15–24. doi:10.1097/00000441-200307000-00003.
   PubMed Web of Science ®Google Scholar
• Martin-Fernandez B, de Las Heras N, Miana M, Ballesteros S, Delgado C, Song S, Hintze T, Cachofeiro V, Lahera V. Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression. J Cardiovasc Pharmacol. 2011;57(1):114–21. doi:10.1097/FJC.0b013e31820088ca.
   PubMed Web of Science ®Google Scholar
• Galmiche G, Pizard A, Gueret A, El Moghrabi S, Ouvrard-Pascaud A, Berger S, Challande P, Jaffe IZ, Labat C, Lacolley P, et al. Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness. Hypertension (Dallas, Tex: 1979). 2014;63(3):520–26. doi:10.1161/HYPERTENSIONAHA.113.01967.
   PubMed Web of Science ®Google Scholar
• Choudhary MK, Varri E, Matikainen N, Koskela J, Tikkakoski AJ, Kahonen M, Niemela O, Mustonen J, Nevalainen PI, Porsti I. Primary aldosteronism: Higher volume load, cardiac output and arterial stiffness than in essential hypertension. J Intern Med 2020. doi:10.1111/joim.13115.
   Google Scholar
• Baer L, Sommers SC, Krakoff LR, Newton MA. Laragh JH: pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism. Circ Res. 1970;27(1 Suppl 1):203–20.
   PubMed Web of Science ®Google Scholar
• Ambrosino P, Lupoli R, Tortora A, Cacciapuoti M, Lupoli GA, Tarantino P, Nasto A, Di Minno MN. Cardiovascular risk markers in patients with primary aldosteronism: A systematic review and meta-analysis of literature studies. Int J Cardiol. 2016;208:46–55. doi:10.1016/j.ijcard.2016.01.200.
   PubMed Web of Science ®Google Scholar